Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with advanced breast cancer (ABC): Final results from EVEREXES

Basit Öğe Kaydı
dc.contributor.authorIm, Y-H.
dc.contributor.authorKarabulut, B.
dc.contributor.authorLee, K. S.
dc.contributor.authorAdhav, A.
dc.contributor.authorPark, B-W.
dc.contributor.authorCinkir, H. Yesil
dc.contributor.authorKim, S-B.
dc.date.accessioned2020-12-01T12:06:32Z
dc.date.available2020-12-01T12:06:32Z
dc.date.issued2019
dc.departmentEge Üniversitesien_US
dc.descriptionEuropean-Society-for-Medical-Oncology (ESMO) Asia Congress -- NOV 22-24, 2019 -- Singapore, SINGAPOREen_US
dc.description.abstract[No abstract available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol, Japanese Soc Med Oncolen_US
dc.description.sponsorshipNovartis Pharmaceuticals CorporationNovartisen_US
dc.description.sponsorshipNovartis Pharmaceuticals Corporation.en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://hdl.handle.net/11454/63238
dc.identifier.volume30en_US
dc.identifier.wosWOS:000503487700040en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSafety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with advanced breast cancer (ABC): Final results from EVEREXESen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu